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Abstract. A previously healthy 9-year-old boy died from acute 
liver failure during an acute Epstein-Barr virus infection. 
Epstein-Barr virus DNA could be demonstrated in the liver by 
Southern blot - and by in situ hybridization techniques. The 
identification of the virus in the liver suggests a causal relation 
between the Epstein-Barr virus and the acute massive liver 
cell necrosis. 
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Introduction 
Infectious mononucleosis characterized by a clinical syn- 
drome with fever, tonsilllopharyngitis, and enlarged cervical 
lymph nodes [12, 17, 22]. The diagnosis has usually been 
based on the demonstration of the typical triad, (1) clinical 
findings compatible with the disease, (2) more than 50% 
mononuclear cells in peripheral blood smears, and (3) the oc- 
currence of heterophilic antibodies [17]. Many children with 
Epstein-Barr virus (EBV) infection do not present with these 
classical features. Therefore, the demonstration of specific 
antibodies of the IgM class in the serum seems necessary to 
confirm an acute infection with EVB [11]. 
The liver is usually involved in the disease but fulminant 
hepatic failure is an unusual finding during the course of infec- 
tious mononucleosis [1, 2, 9, 10]. It seems to occur more fre- 
quently in patients with X-linked recessive lymphoprolifera- 
tive syndrome [15, 16]. In the past, demonstration f a causal 
relation between EBV and liver cell necrosis was not possible. 
Recently developed techniques of nucleic acid hybridization 
now allow a correlation between EBV and specific cell types 
to be shown [24]. 
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We describe the case of a previously healthy boy with in- 
fectious mononucleosis who developed an acute hepatic fail- 
ure. In this patient EBV was demonstrated in liver tissue 
taken immediately after death using two different nucleic acid 
hybridization techniques. 
Case report 
A previously healthy 8-year-ll-month-old boy presented with 
a history of fatigue, discomfort, upper abdominal pain and 
fever (38~ of 9 days duration [6]. His parents had noted a 
darkening of the skin and a dark urine. His physician had 
noted a swelling of cervical glands, sinusitis and pleural effu- 
sions. On the day prior to admission total serum bilirubin was 
46 gmol/1, the conjugated fraction 39.2 gmol/1, alanine amino- 
transferase (ALT) 306 U/l, and gammaglutamyltransferase 
174 U/1. The family history did not reveal any signs of immuno- 
deficiency. 
On admission the patient was jaundiced, had enlarged cer- 
vical glands, inflamed tonsils with white-yellow stipples, and 
the liver and spleen were palpable 1.5 cm below the costal 
margin [6]. The peripheral blood smear showed 72% (= 8.7/nl) 
atypical mononuclear cells (Rieder-Glanzmann). The patient 
was febrile and treatment was started with erythromycin-suc- 
cinate and noramidopyriniummethane sulphonate-sodium 
(Novalgin). 
The boy developed clinical and laboratory signs of liver 
failure (ALT 1372 U/l, asparate aminotransferase 3640 U/l, 
bilirubin 145 ~tmol/1) with severe alterations of the coagulation 
system: thromboplastin time 18% (normal >70%),  partial 
thromboplastin time 128 s (normal 35-55 s), thrombin time 
128 s (normal 17-24 s), fibrinogen < 50 mg/dl (normal > 150 
mg/dl), Factor II 13% (normal > 80%), factor V 38% (normal 
>80%),  factor VII 17% (normal >80%),  factor VIII  120% 
(normal > 80%) and 39% respectively, antithrombin II I 40% 
(normal >80%),  thrombocytes 56/nl, on the 6th day after ad- 
mission [6]. Erythromycin and antipyretics were withdrawn, 
and the patient was treated by daily exchange transfusions 
with fresh blood. Lactulose and neomycin administration was 
started orally, and he had a short course of silymarin and 
penicillin. Substitutions with coagulation factor concentrates, 
vitamin K, and antithrombin III could not improve the coa- 
gulation disorder nor prevent further bleeding. After resus- 
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citation from a cardiac arrest on the 9th day he developed a
terminal renal insufficiency [6] and died on the 15th day of his 
illness. 
Heterophilic antibodies against horse erythrocytes were 
detected by Monospot (Ortho Diagnostic Systems, Heidel- 
berg, FRG) and IM-Quicktest (Human Corporation, Taunus- 
stein-Neuhof, FRG), and the reaction of Paul-Bunnell 
(against sheep erythrocytes) was positive at a titre of 1:16. 
Specific antibodies (EBV-VCA, immune fluorescence) of the 
IgM class were shown to be positive at a titre of 1:64, and 
antibodies of the IgG class were shown to be positive at a titre 
of 1:256 [6]. Infections with ornithosis, influenza A and B, 
mycoplasma pneumoniae, parainfluenza 1,2,3, Q-fever, 
mumps, adenovirus, cytomegalovirus, echoviruses or cox- 
sackieviruses were excluded by negative complement binding 
reactions (KBR), infections with measles or rubella viruses 
were excluded by negative haemagglutination, toxoplasmosis 
by negative immune fluorescence and hepatitis A and B were 
excluded by negative radioimmunoassay. 
Antibodies to respiratory syncytial virus, herpes simplex 
and varicella viruses were shown to be positive at a titre of 
1 : 10 (KBR). The serum levels of caeruloplasmin, copper, and 
alpha~-antitrypsin were within the reference ranges of our lab- 
oratory. The total IgM level in serum was 4.02 g/l, total IgG 
and total levels IgA were normal. 
Methods 
A complete postmortem examination was done. Histologic 
examinations were performed on liver, gall bladder, gastro- 
intestinal tract, spleen, lymph nodes, lung, kidney, skin and 
brain sections (routine HE, PAS, trichrome staining, addi- 
tional staining of liver sections with Giemsa, diastase-PAS, 
iron-staining and reticulin-staining). Portions of liver tissue 
were frozen at -70~ and were stored for 1 month, until nuc- 
leic acid hybridization tests were performed. These tests were 
based either on DNA extracted from tissue (Southern blot, 
[19]) or were directly performed on sections of frozen tissue 
(in situ hybridization). The tissue-derived DNA was dena- 
tured to yield single-stranded DNA, incubated with equally 
single-stranded radioactively labelled viral DNA, thoroughly 
washed and exposed to autoradiography. Positive hybridiza- 
tion signals were regarded as markers for the presence of viral 
DNA. 
1) Procedure of Southern blot hybridization [18]. Liver cell 
DNA was extracted, igested with BamH1 endonuclease, sep- 
arated on a 0.8% agarose gel denatured with 0.5 N NaOH, neu- 
tralized and transferred to a nitrocellulose filter by blotting. 
To determine the sensitivity, Rail-cell DNA was included as a 
control. According to reassociation kinetic experiments, each 
Raji cell contains 50 copies of EBV-DNA [25], slot 1:20 gg, 
slot 2:2 gg, slot 3:0.4 gg, slot 4:0.2 ~tg, and was processed in 
the same way. The blots were incubated at 68~ in 6 x SSC, 
0.5% SDS, 5 x Denhardt's olution [5] with the addition of 
100 ~tg/ml denatured calf tyhmus DNA. After 4 h the excess 
prehybridization mix was removed, I12Llabelled EBV-specific 
single-stranded hybridization probe MEBWS7 added and the 
incubation continued for another 16 h. After hybridization the 
filter was washed at 68~ in several changes of 2 x SSC, dried 
and exposed for 12 h. 
The hybridization probe was derived by subcloning an 
internal repeat of EBV-DNA (W-Band after digestion with 
BamHI) after SauIIIa digestion into the double-stranded re- 
plicative form of m13mp8 bacteriophage. The infected bac- 
teria release recombinant m13 phage containing single- 
stranded recombinant DNA. This DNA can be labelled effi- 
ciently (specific activity 5 x 108cpm/gg) in the presence of 
TI 3+ with 1125 in a chemical reaction [8]. 
2) Procedure of in situ hybridization [23]. Frozen sections of 
liver tissue 8 gm thick were fixed in a solution containing 
3 parts methanol and 1 part concentrated acetic acid, incu- 
bated in 2 x SSC (1 x SSC = 0.15M sodium chloride, 0.015 M 
sodium citrate) at 70~ for 30 min and treated with proteinase- 
K at 37~ for 15 min. Immediately before hybridization the 
preparations were denatured in 0.1 • SSC at 98~ for 3 s, chil- 
led in the same buffer at 0~ and dried. 
Fig. 1. Postmortem punctate of the liver, 
trichrom, 324 • Mononuclear cell 
infiltrates, necrosis of Kupffer cells and of 
liver cells 
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The hybridization probe contained 105 cpm 3H-labelled 
EBV-DNA with a specific activity of about 5 x 106 cpm/gg in 
50% formamide, 0.6M sodium chloride, 10raM Tris-HC1, 
pH 7.5, i mM EDTA, 100 ~tg/ml calf thymus DNA, 1 mg/ml 
bovine serum albumin, 1 mg/ml tRNA, 100 gg/ml Poly A, 
0.02% wt/vol polyvinylpyrrolidone, 0.02% wt/vol Ficoll. The 
preparations were covered by 10 gl of this solution enclosed 
under a cover slip and sealed with Fixogum (Marabuwerke, 
Tamm, FRG). The hybridization was continued at 40~ for 
4 h. The covering was then removed and the sections washed 
in five changes of formamide buffer (identical to hybridization 
solution, but without added polyanions) for a total of 15 h, 
rinsed with 2 x SSC, and dried. Then the preparations were 
dipped into Kodak-NTB emulsion (diluted 1 : 1 in 6 mM am- 
monium acetate, 40~ dried and exposed at 4~ for 3 weeks. 
After development (Kodak-D-19 X-ray-film developer) they 
were stained with Giemsa. 
Results 
The postmortem examination revealed a necrosis of 95% of 
liver parenchyma with little regeneration i the periphery of 
liver lobules (Fig. 1). A few proliferating bile ductules were 
seen. Portal triads and sinusoids were massively infiltrated by 
monocytes and histiocytes. Kupffer cells were enlarged and 
showed single necroses [6]. There was no cholestasis, no fat 
depositions or infiltration by eosinophilic leucocytes. 
The skin was jaundiced and exhibited petecchial bleeding. 
Massive bleeding was also seen into the peritoneum and peri- 
toneal cavity, into gall bladder wall and cavity, into gastro- 
intestinal tract, lymph nodes, lungs, myocardium, subepicar- 
dially and subendocardially, and into the kidneys. The kid- 
neys showed tubular epithelial necroses [6]. A severe cerebral 
oedema was noted. 
Hybridization studies 
The autoradiographic pictures of "Southern blot" (Fig. 2) as 
well as of in situ hybridization (Fig. 3) showed a positive re- 
sult. Because 0.5 gg Raji DNA (50 viral genomes per cell) 
shows a hybridization signal similar to 10 gg patient liver DNA 
the EBV genome content per average liver cell is 2.5. The 
black granules in Fig. 3 were caused by the radiation gener- 
ated by the decay of radioactively labelled viral test DNA 
(EBV-DNA). This single-stranded test DNA was specifically 
bound to the complementary strands of "resident" EBV-DNA 
and formed a double-stranded EBV-DNA sequence. The 
granules could not be allocated to a certain cell type due to 
damaged cell structures caused by tissue necrosis and prepara- 
tion artefacts. 
Fig. 2. Southern blot hybridization (W S7ss DNA 125 J): positions 1-5: 
Raji/Bam HI 2 gg, 1 gg, 0.5 Ixg, 0.2 gg, 0.1 gg/slot. Position 6: patient 
H.T., liver tissue DNA/BamHI 10 gg/slot 
Discussion 
Liver involvement in acute EBV infections occurs in up to 
95% of patients between the 6th and 15th day of illness and is 
usually mild [17]. 
Harries and Ferguson reported two instances of fulminant 
hepatic failure in infants [9]. Their diagnosis was based on 
clinical and laboratory features and on the demonstration of
heterophilic antibodies in the older girl. Both children died on 
the 26th and 28th days, respectively. Recently, another girl 
aged 14 years had been reported to have died from fulminant 
hepatic failure during the acute stage of an EBV infection 
[10]. The diagnosis was confirmed serologically by an EBV 
VCA-IgM titre of 1 : 640, but a postmortem examination was 
not performed. There is no doubt that our patient suffered 
from an acute EBV infection. The clinical picture (tonsillitis, 
enlargement of cervical glands), peripheral blood smears, the 
presence of heterophilic antibodies in two different tests and 
specific antibodies of the IgM type confirm this infection [6, 
11, 17, 22]. 
In male patients with X-linked lymphoproliferative syn- 
drome a high incidence of massive hepatic necrosis during 
EBV infections was encountered [15, 16]. Purtilo suggested 
that immunodeficiency states are necessary for development 
of an acute liver failure [16]. In our patient, family history, 
clinical and laboratory data made the diagnosis of pre-existing 
immunodeficiency very unlikely. 
Histologically, the liver involvement is usually charac- 
terized by a dense infiltration of portal triads and sinusoids by 
monoclear cells, by an activation of Kupffer cells and by focal 
liver cell necrosis [20]. Massive hepatic necroses have rarely 
been seen in adults [1, 2] and in children without immuno- 
deficiencies [10, 15]. Histological examination of the liver in 
our patient suggested EBV as a cause of the liver disease, 
there were no indications of drug-induced liver disease [7, 14, 
21, 27]. 
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l~g.3. In situ hybridization of liver tissue of patient H.T. Giemsa, 
188 x. Single-stranded test DNA is specifically bound to single- 
stranded wild-type EBV-DNA to form a double-stranded EBV-DNA 
sequence (arrows) 
Since massive hepatic necroses, as mentioned above, have 
only rarely been reported, the identification of EBV in liver 
tissue seemed necessary to support he diagnosis. Nucleic acid 
hybridization techniques have been used successfully to dem- 
onstrate EBV-DNA in tumour cells of nasopharyngeal car- 
cinoma and in poorly differentiated carcinomas of the tonsils 
[23]. These methods are based on the ability of single- 
stranded viral test DNA to form stable double strands with 
other nucleic acids with complementary sequences of at least 
five successive nucleotides [24]. Highly specific hybridization 
probes are obtained by cloning of viral DNA in plasmid vec- 
tors; cross reactions with closely related viruses can then be 
excluded by selecting appropriate fragments [24]. The sen- 
sitivity of the test system is determined by the specific radio- 
activity of the tracer DNA. In the case of in situ hybridizations 
the multiplying effect of the transcription of active viral genes 
can be used to achieve higher signals. In these preparations 
artefacts produced by DNA-binding proteins or local desic- 
cations cannot completely be excluded [24]; therefore, it is 
preferable to use another independent technique to confirm 
the results. In our case we used purified DNA digested with 
restriction enzymes for the detection of viral sequences. The 
use of purified DNA excludes protein-mediated artefacts and 
restriction enzymes upon gelelectrophoresis create highly spe- 
cific bands detectable with specific hybridization. 
Southern blot hybridization and in situ hybridization were 
used for the first time to demonstrate EBV in the liver tissue 
of a patient. The demonstration of highly concentrated EBV- 
specific DNA in liver tissue confirms the presence of replica- 
rive Epstein-Barr viruses and suggests a causal relation be- 
tween EBV and the acute hepatic necrosis. However, the 
pathologic mechanism of the massive necrosis of liver cells re- 
mains unclear, Immunologic mechanisms may play a role. The 
virus seems to enter the body in the nasopharynx and rapidly 
colonizes B-lymphocytes. This causes a T-cell and antibody 
response to terminate the infection [26]. Some T-cell defects 
apparently induced by EBV [4, 13] and the frequency of mas- 
sive hepatic necrosis in patients with X-linked lymphopro- 
liferative syndrome and EBV infection [15,16] support his 
theory. 
Unfortunately, the virus could not be allocated to a certain 
cell type. It possibly infiltrates the liver within lymphocytes. 
Whether it infiltrates the parenchymal cells of the liver in a 
similar way to epithelial cells of carcinomas [3, 23] and 
whether it exhibits a direct toxic effect on the liver cell re- 
mains to be elucidated. 
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